SCHEMBL2189766

SCHEMBL2189766

O=C(OCc1ccccc1)N1CCc2[nH]c3ccc(Cl)cc3c2C1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 5/20 0.63
LMNA P02545 2/20 0.60
PABPC1 P11940 1/20 0.60
ATM Q13315 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
MAPT P10636 4/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
GAA P10253 2/20 0.57
MAPK1 P28482 2/20 0.57
ALOX15 P16050 1/20 0.57
ALOX12 P18054 1/20 0.57
CASP1 P29466 1/20 0.57
CASP7 P55210 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
PTGDR2 Q9Y5Y4 5/20 0.53
AKR1B1 P15121 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61901 0.88 LMNA (0.60) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL12868460 0.87 MAPT (0.62) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL12868340 0.86 LMNA (0.79) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL7132310 0.81 LMNA (0.68) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL28475633 0.81 BAZ2B (0.79) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL62381 0.79 ROCK2 (0.51) LMNAPABPC1ATMSMN1; SMN2KMT2A
SCHEMBL21114757 0.79 BAZ2B (0.71) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL1000954 0.78 TRPV1 (0.69)
SCHEMBL3308539 0.78 MAPK1 (0.54) BAZ2BLMNAPABPC1ATMSMN1; SMN2
SCHEMBL31315788 0.78 GABRA5 (0.53) PTGDR2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-8907097-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
EP-2346332-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES Medivation Technologies, Inc. (US) 2011-07-27 EP disclosed
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2010-08-26 US disclosed
WO-2010051501-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A BAZ2B 1572/4885LMNA 3212/4885PABPC1 3322/4885
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A BAZ2B 1572/4885LMNA 3212/4885PABPC1 3322/4885
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A BAZ2B 1572/4885LMNA 3212/4885PABPC1 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.